Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : Vatalanib
CAS No.: 212141-54-3
Catalog No.: PC-42448Not For Human Use, Lab Use Only.
Vatalanib (PTK787) is a potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 25 mg | $98 | In stock | |
| 50 mg | $148 | In stock | |
| 100 mg | $248 | In stock | |
| 250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Vatalanib (PTK787) is potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.
Vatalanib (PTK787) shows no activity against EGFR, FGFR-1, c-Met, and Tie-2, or c-Src, c-Abl, and PKC-α.
Vatalanib (PTK787) blocks the VEGF-induced receptor autophosphorylation in CHO cells ectopically expressing the KDR receptor with IC50 of 34 nM.
Vatalanib (PTK787) inhibits EGF and PDGF-induced angiogenesis in a growth factor implant model (25-100 mg/kg).
| M.Wt | 346.8129 | |
| Formula | C20H15ClN4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)- |
|
1. Bold G, et al. J Med Chem. 2000 Jun 15;43(12):2310-23.
2. Wood JM, et al. Cancer Res. 2000 Apr 15;60(8):2178-89.
3. Drevs J, et al. Cancer Res. 2000 Sep 1;60(17):4819-24.
4. Hess C, et al. Br J Cancer. 2001 Dec 14;85(12):2010-6.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
